Status:
COMPLETED
Estrogen and Perimenopausal Depression
Lead Sponsor:
University of California, Los Angeles
Collaborating Sponsors:
National Alliance for Research on Schizophrenia and Depression
Conditions:
Depressive Disorder, Major
Menopause
Eligibility:
FEMALE
40-60 years
Phase:
PHASE4
Brief Summary
During perimenopause (the time just prior to menopause), women often notice many biological, psychological, and social changes. In particular, some women experience depressive symptoms during perimeno...
Eligibility Criteria
Inclusion
- Clinical Diagnosis of Unipolar Major Depression, currently taking antidepressants
- HAM-D between 10 and 17
Exclusion
- History of Psychosis, breast cancer, smoking, dementia, clotting disorders
- Current substance abuse
Key Trial Info
Start Date :
April 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2004
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT00229450
Start Date
April 1 2002
End Date
August 1 2004
Last Update
February 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA Neuropsychiatric Institute & Hospital
Los Angeles, California, United States, 90024